Clinical Trials Logo

Malignant Melanoma of Skin clinical trials

View clinical trials related to Malignant Melanoma of Skin.

Filter by:
  • None
  • Page 1

NCT ID: NCT06014086 Recruiting - Clinical trials for Squamous Cell Carcinoma of the Skin

Intratumoral PH-762 for Cutaneous Carcinoma

Start date: November 7, 2023
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to evaluate the safety and tolerability of intratumoral injections of PH-762 in squamous cell carcinoma, melanoma, or Merkel cell carcinomas of the skin, to understand what the body does to the PH-762, and to observe how the tumor responds to the drug. Participants will receive four injections of PH-762 at weekly intervals, into a single tumor, followed by surgical removal of the tumor approximately two weeks later.

NCT ID: NCT02668887 Completed - Quality of Life Clinical Trials

Employment and Quality of Life in Patients With Malignant Melanoma

Start date: April 2016
Phase:
Study type: Observational

Within the first year after diagnosis, data on employment and quality of life will be collected and evaluated in patients with malignant melanoma